Skip to main content
. 2015 Jun 15;8(6):9549–9554.

Figure 2.

Figure 2

Progression-free survival analysis for the prognosis of adenomyosis. Kaplan-Meier method was performed to analyze the progression-free survival rate for the prognosis of adenomyosis patients according to the levels of VEGF and CA125 in serum. A total of 80 patients were followed up 12 months after interventional therapy. Based on the serum levels of VEGF and CA125 before surgery, the median levels of VEGF and CA125 were 168 pg/ml and 110 ku/l, respectively.